Monday, October 20, 2025

Numinus Wellness Receives Health Canada Amendment To Study Psilocybin Extraction

Numinus Wellness (TSXV: NUMI) this morning had a significant update, announcing that it has received approval from Health Canada to enable the firm to conduct research to standardize the extraction of psilocybin from mushrooms. The approval is stated by the firm to be the first of its kind in Canada.

Under the new license, Numinus will be able to produce naturally sourced psilocybin extract for research purposes. The production is intended to support psychedelic assisted therapy and research at a lower cost than currently produced synthetic variants. The company will also be able to develop and license its own IP as a result.

Numinus will now focus on developing an extraction method to allow for “consistent dosing and application of naturally produced psilocybin.” The company intends to enter supply agreements within the space once these methods of extraction are developed.

A timeline was not provided for such agreements.

Numinus Wellness last traded at $0.60 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

Numinus Releases 2020 Operational Objectives

Numinus Wellness (TSXV: NUMI) released its near term 2020 objectives this morning related to its...

Thursday, May 28, 2020, 08:33:29 AM

Numinus Wellness Announces Expansion To Research Lab

Numinus Wellness (TSXV: NUMI) has expansion on its mind. The company this morning announced that...

Tuesday, March 9, 2021, 08:18:23 AM

Numinus Wellness Sells Off Shares In Alto Neuroscience Ahead Of IPO

Numinus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in...

Thursday, February 1, 2024, 09:28:12 AM

Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract

Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this...

Monday, April 26, 2021, 07:10:35 AM

Numinus Sells Utah Clinics For US$3.53 Million

Numinus Wellness (TSX: NUMI) is disposing of its US-based clinics in a transaction that is...

Friday, November 15, 2024, 08:03:39 AM